Related Experiment Video
Updated: Oct 14, 2025

06:32
Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor
Published on: May 2, 2025
483
[Platelet function tests and Chinese medicines with antiplatelet function:a review].
Shun-Li Xiao1, Shi-Lan Ding1, Zheng-Xiao Sun1
1Institute of Chinese Materia Media, China Academy of Chinese Medical Sciences Beijing 100700, China.
Summary
Chinese medicines contain active constituents with antiplatelet effects, primarily at micromolar levels. Further research into structure-activity relationships is needed to enhance their efficacy compared to conventional drugs.
Area of Science:
- Pharmacology
- Traditional Chinese Medicine
- Biochemistry
Background:
- Platelet function tests are crucial for diagnosing platelet disorders, assessing thrombotic risk, and monitoring antiplatelet therapy.
- While light transmission aggregometry is established, novel platelet function tests are emerging.
- Platelet function detector development in China is still in its early stages.
Purpose of the Study:
- To review and analyze methods for determining platelet function.
- To summarize research on the antiplatelet effects of Chinese medicines and their active constituents.
- To provide insights for developing effective and safe antiplatelet Chinese medicines.
Main Methods:
- Classification of active constituents in antiplatelet Chinese medicines (terpenoids, flavonoids, etc.).
- Analysis of dose-response relationships for Chinese medicines and their active components.
- Identification of specific compounds like salvianolic acid B and ginkgolides with potent antiplatelet activity.
Main Results:
- Effective concentrations of Chinese medicine extracts/monomers are in the micromolar range (μmol·L⁻¹).
- Salvianolic acid B, ginkgolide K, B, and A exhibit the strongest antiplatelet effects.
- The antiplatelet effects of Chinese medicines involve multiple pathways and targets, potentially weaker than chemical drugs.
Conclusions:
- Chinese medicines offer potential for antiplatelet therapy, but efficacy may require structure-activity relationship exploration and modification.
- Large-scale clinical trials are needed to validate the efficacy and safety of these agents.
- Further research into signal transduction pathways and structure-activity relationships is essential.
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
744
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
744
Structure and Function of Platelets
2.2K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
2.2K

